Skip to main content
Tabetha R. Harken

Tabetha R. Harken

•Health Sciences Clinical Professor, Department of Obstetrics and Gynecology, University of California, Irvine
•Program Director of Complex Family Planning Fellowship, Department of Obstetrics and Gynecology, University of California, Irvine

Biography

Tabetha R. Harken, M.D., M.P.H., F.A.C.O.G., is Health Sciences Clinical Professor, Program Director of Complex Family Planning Fellowship, Division Director of Family Planning, and Director of the Ryan Residency Abortion & Contraception Training Program in the Department of Obstetrics and Gynecology at the University of California, Irvine. She received her M.D. from the University of Colorado School of Medicine and her M.P.H. from George Washington University School of Public Health. After completing her residency in Obstetrics and Gynecology at the University of Colorado, she completed a fellowship in Family Planning at the University of California, San Francisco, where she also received advanced training in clinical research. Harken is subspecialty board certified in Complex Family Planning.

Harken's clinical and research work focuses on complex abortion care, cesarean scar ectopic pregnancies, and perinatal loss. She has served as Principal Investigator on multiple grants, including a $1.4 million Comprehensive Reproductive and Maternal Services Grant and a $300,000 grant from Hoag Memorial Hospital Presbyterian Community Benefit Program for creating a culture of compassionate care for women experiencing pregnancy loss. Her research has been published in journals including Obstetrics & Gynecology, Contraception, and BMC Public Health, and she has presented at national conferences including the American College of Obstetrics & Gynecology Annual Meeting and the Society of Family Planning Annual Meeting. She has conducted international consultation work on abortion care and contraception in Nepal, Mexico, Vietnam, and Canada.

Harken has held leadership positions at UCI since 2009, including serving as Division Director of Family Planning since 2014 and Director of the Ryan Residency Abortion & Contraception Training Program since 2010. She serves as the OB/GYN Wellness Officer for her department and is a founding member of the Reproductive Justice Initiative, a collaborative across UCI's Schools of Medicine, Law, Nursing, and Business. She has been invited to provide expert testimony on reproductive health policy to the California State Senate and the University of California Office of the President Health Services Committee. Harken is a Fellow of the Society of Family Planning and the American College of Obstetricians and Gynecologists.

Return to top

Education

  • B.S., Georgetown University, 1996
  • M.P.H., George Washington University, 1998
  • M.D., University of Colorado School of Medicine, 2002
Return to top

Distinctions

  • Gold Foundation Humanism and Excellence in Teaching Award, 2005
  • Fellow, American Board of Obstetrics and Gynecology (FACOG), 2011
  • ACOG First Place Award, Poster Presentation, 2005
  • Kirk Keegan, Jr., MD Faculty Teaching Award for Excellence in Resident Education, 2016, 2024
  • Kirk Keegan, Jr., MD Faculty Teaching Award for Excellence in Medical Student Education, 2011, 2018
  • Ravin Award in Family Medicine for Excellence in Medical Education, 2002
  • Outstanding Resident Teaching Award, UCSF, 2009
  • Southern California Rising Stars, SuperDoctors, 2014-2015, 2019-2024
  • Award for Excellence, Colorado OB/GYN Society, 2002
  • Orange County Physicians of Excellence Award, Orange Coast Magazine, 2017-2025
Return to top

Areas of Expertise

  • Reproductive Health Services
  • Abortion Legalization Effects
  • Contraceptive Method Selection
  • Perinatal Loss Bereavement
  • Cesarean Scar Ectopic Pregnancy
  • Intimate Partner Violence Screening
  • Postpartum Contraception Initiation

Recent Publications

Return to top

Contact Information

Email: tharken@uci.edu

Phone: (714) 456-5967

Return to top

This profile was created with the help of AI.

Last updated on 5/19/2026.